Christina (Tina) P.: Can Vitamin K Help Stabilize Your INR?
Christina (Tina) P., CEO and Co-Founder of APS Foundation of America, shared on LinkedIn about an article by Elizabeth Sconce et al, published in Blood, adding:
”Problems Stabilizing Your INR?: APS Awareness Month Day 16
If you walk into a dark room and switch on a 3-way light, you notice a huge increase in the amount of light.
If you switch to the next higher level, you do not notice as much change, even though the increase is the same number of watts.
A similar thing happens when someone takes tiny amounts of Vitamin K from eating vegetables.
If this person then gets a little more vitamin K1, then the INR can be thrown off.
To get around this, some warfarin managers have tested giving people a known amount of vitamin K1.
Then they assessed whether the INRs became more consistent.
This is a great paper to share with your care providers and discuss.
Many other medical journals support this same theory.
A study done in the UK followed 70 people who had unstable INRs.
They were divided into two groups – those getting 150 mcg of vitamin K1 daily and those getting a placebo.
The people getting the vitamin K1 had more consistent INRs higher than those of the people getting the placebo.
Each person’s INRs for 6 months on the study were compared with their INRs for 6 months before the study.
It appears that taking a known amount of vitamin K1 daily and adjusting the increasing the warfarin dose to accommodate these results in more stable INRs.
Reference: Sconce E. et al. Vitamin K1 supplementation can improve stability of anticoagulation for patients with unexplained variability in response to
warfarin. Citation: Blood. 2006; Nov 16.
This is a great paper to share with your care providers and discuss.
Many other medical journals support this same theory.”
Title: Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin
Authors: Elizabeth Sconce, Peter Avery, Hilary Wynne, Farhad Kamali
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 17, 2026, 15:46Heghine Khachatryan: Clinical Context at the Core of Thrombosis and Thrombophilia Management
-
Sep 17, 2026, 15:33Alexandros Makis: When Microcytic Anemia Has an Inherited Cause
-
Sep 17, 2026, 15:22α2-Antiplasmin Inhibition and the Future of Thrombolysis
-
Sep 17, 2026, 15:20Fatma M. Attia: Expanding the Evidence Base for Therapeutic Plasma Exchange Across Multiple Indications
-
Sep 17, 2026, 15:19Conan McIlwrath: The Haemophilia Society Engages With IBCA
-
Sep 17, 2026, 15:06Eleftheria Hatzimichael: A Contemporary Diagnostic Approach to Inherited Microcytic Anemias
-
Sep 17, 2026, 14:51Konstantin Yenkoyan: Emicizumab and the Power of Translational Science
-
Sep 17, 2026, 14:47Zachary Sutton: Translating the 2026 KDIGO Guideline Into Practice
-
Sep 17, 2026, 14:43Leah Williams: Evaluating Medical Device Haemocompatibility Under ISO 10993-4